Michal Nozdrzykowski

Dr. Michal Nozdrzykowski


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2022 in Journal of Artificial Organs
Verified
Journal Article
Closed access
PDF file
MNMichal Nozdrzykowski
Michal Nozdrzykowski
TNThilo Noack
Thilo Noack
USUwe Schulz
Uwe Schulz
CLChristian Luecke
Christian Luecke
MBMichael A. Borger
Michael A. Borger
DSDiyar Saeed
Diyar Saeed

20 June 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
MDMaja-Theresa Dieterlen
Maja-Theresa Dieterlen
LHLea Hildebrandt
Lea Hildebrandt
KKKristin Klaeske
Kristin Klaeske
JJJoanna Jozwiak-Nozdrzykowska
Joanna Jozwiak-Nozdrzykowska
MBMichael Borger
Michael Borger
MNMichal Nozdrzykowski
Michal Nozdrzykowski
Introduction: The implantation of a left ventricular assist device (LVAD) is a life-saving therapeutic option for patients with advanced heart failure. The treatment goal has to be determined prior to LVAD implantation. However, prognostic evaluation for defining the treatment goal could be improved for a time- and cost-effective medical treatment. Methods: Our study comprised seven patients who were weaned from LVAD (recovery group) and a control group without weaning (non-recovery group; n = 7). Myocardial tissue was analysed for connective tissue content by Masson–Goldner trichrome staining and for collagen I and collagen III expression by quantitative real-time PCR and immunohistochemistry. Results: The histological evaluation revealed comparable values for the percentage of total connective tissue (non-recovery: 46.3% [95% CI: 15.9–76.7], recovery: 43.4% [95% CI: 13.7–73.2], p = 0.43). mRNA expression analysis for collagen I and III expression could not detect a difference in collagen I (p = 0.16) and collagen III expression (p = 0.12) between the non-recovery and the recovery group. Immunohistochemical staining revealed that the percentages of collagen I (p = 0.05) and of collagen III (p = 0.01) were reduced in patients who do not recover compared to patients who recover under LVAD support. Conclusions: Our data indicate that histological evaluation for collagen expression prior to LVAD implantation could detect differences in the collagen content that could be helpful for estimating the weaning success.